BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goswami S, Anandhan S, Raychaudhuri D, Sharma P. Myeloid cell-targeted therapies for solid tumours. Nat Rev Immunol 2022. [PMID: 35697799 DOI: 10.1038/s41577-022-00737-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Martín-Otal C, Lasarte-Cia A, Serrano D, Casares N, Conde E, Navarro F, Sánchez-Moreno I, Gorraiz M, Sarrión P, Calvo A, De Andrea CE, Echeveste J, Vilas A, Rodriguez-Madoz JR, San Miguel J, Prosper F, Hervas-Stubbs S, Lasarte JJ, Lozano T. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. J Immunother Cancer 2022;10:e004479. [PMID: 35918123 DOI: 10.1136/jitc-2021-004479] [Reference Citation Analysis]
2 Gong Z, Li Q, Shi J, Wei J, Li P, Chang C, Shultz LD, Ren G. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity 2022. [DOI: 10.1016/j.immuni.2022.07.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]